Warrick A - Search Results

1

Novel method for PIK3CA mutation analysis: locked nucleic acid--PCR sequencing.

Ang D, O'Gara R, Schilling A, Beadling C, Warrick A, Troxell ML, Corless CL. Ang D, et al. Among authors: warrick a. J Mol Diagn. 2013 May;15(3):312-8. doi: 10.1016/j.jmoldx.2012.12.005. Epub 2013 Mar 27. J Mol Diagn. 2013. PMID: 23541593 Free article.

2

Frequent phosphatidylinositol-3-kinase mutations in proliferative breast lesions.

Ang DC, Warrick AL, Shilling A, Beadling C, Corless CL, Troxell ML. Ang DC, et al. Among authors: warrick al. Mod Pathol. 2014 May;27(5):740-50. doi: 10.1038/modpathol.2013.197. Epub 2013 Nov 1. Mod Pathol. 2014. PMID: 24186142 Free article.

3

High prevalence of PIK3CA/AKT pathway mutations in papillary neoplasms of the breast.

Troxell ML, Levine J, Beadling C, Warrick A, Dunlap J, Presnell A, Patterson J, Shukla A, Olson NR, Heinrich MC, Corless CL. Troxell ML, et al. Among authors: warrick a. Mod Pathol. 2010 Jan;23(1):27-37. doi: 10.1038/modpathol.2009.142. Epub 2009 Nov 6. Mod Pathol. 2010. PMID: 19898424 Free article.

4

Multiplex mutation screening by mass spectrometry evaluation of 820 cases from a personalized cancer medicine registry.

Beadling C, Heinrich MC, Warrick A, Forbes EM, Nelson D, Justusson E, Levine J, Neff TL, Patterson J, Presnell A, McKinley A, Winter LJ, Dewey C, Harlow A, Barney O, Druker BJ, Schuff KG, Corless CL. Beadling C, et al. Among authors: warrick a. J Mol Diagn. 2011 Sep;13(5):504-13. doi: 10.1016/j.jmoldx.2011.04.003. Epub 2011 Jul 2. J Mol Diagn. 2011. PMID: 21726664 Free PMC article.

5

Phosphatidylinositol-3-kinase pathway mutations are common in breast columnar cell lesions.

Troxell ML, Brunner AL, Neff T, Warrick A, Beadling C, Montgomery K, Zhu S, Corless CL, West RB. Troxell ML, et al. Among authors: warrick a. Mod Pathol. 2012 Jul;25(7):930-7. doi: 10.1038/modpathol.2012.55. Epub 2012 Mar 30. Mod Pathol. 2012. PMID: 22460814 Free article.

6

Mucinous breast carcinomas lack PIK3CA and AKT1 mutations.

Kehr EL, Jorns JM, Ang D, Warrick A, Neff T, Degnin M, Lewis R, Beadling C, Corless CL, Troxell ML. Kehr EL, et al. Among authors: warrick a. Hum Pathol. 2012 Dec;43(12):2207-12. doi: 10.1016/j.humpath.2012.03.012. Epub 2012 Jun 15. Hum Pathol. 2012. PMID: 22705004

7

Biphasic papillary and lobular breast carcinoma with PIK3CA and IDH1 mutations.

Ang D, VanSandt AM, Beadling C, Warrick A, West RB, Corless CL, Troxell ML. Ang D, et al. Among authors: warrick a. Diagn Mol Pathol. 2012 Dec;21(4):221-4. doi: 10.1097/PDM.0b013e31826ddbd1. Diagn Mol Pathol. 2012. PMID: 23111200

8

PIK3CA-AKT pathway mutations in micropapillary breast carcinoma.

Flatley E, Ang D, Warrick A, Beadling C, Corless CL, Troxell ML. Flatley E, et al. Among authors: warrick a. Hum Pathol. 2013 Jul;44(7):1320-7. doi: 10.1016/j.humpath.2012.10.018. Epub 2013 Jan 24. Hum Pathol. 2013. PMID: 23352210

9

Frequent PIK3CA mutations in radial scars.

Wolters KL, Ang D, Warrick A, Beadling C, Corless CL, Troxell ML. Wolters KL, et al. Among authors: warrick a. Diagn Mol Pathol. 2013 Dec;22(4):210-4. doi: 10.1097/PDM.0b013e318288b346. Diagn Mol Pathol. 2013. PMID: 24193002

10

Novel mutations in neuroendocrine carcinoma of the breast: possible therapeutic targets.

Ang D, Ballard M, Beadling C, Warrick A, Schilling A, O'Gara R, Pukay M, Neff TL, West RB, Corless CL, Troxell ML. Ang D, et al. Among authors: warrick a. Appl Immunohistochem Mol Morphol. 2015 Feb;23(2):97-103. doi: 10.1097/PDM.0b013e3182a40fd1. Appl Immunohistochem Mol Morphol. 2015. PMID: 25679062

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

44 results

Search Page

Filters